Suchergebnisse - "Gahrton, Gösta"

PubPharm (179)

1

Minimal residual disease status is the prognostic determinant following high-dose treatment for patients with multiple myeloma

enthalten in: Cancer medicine | 2023

von Nahi, H. | Afram, G. | Uttervall, K. | +8

2

CAR T-cell treatment of high-risk multiple myeloma : will there be a cure?

enthalten in: Haematologica | 2023

von Gahrton, G.

CommentOn: Haematologica. 2023 Oct 01;108(10):2799-2802. - PMID 36815380

3

Response to Caravita di Toritto and Rago

enthalten in: European journal of haematology | 2023

von Chaireti, R. | Uttervall, K. | Luong, V. | +6

CommentOn: Eur J Haematol. 2023 Feb;110(2):221. - PMID 36300853

4

Minimal residual disease status is the prognostic determinant following high‐dose treatment for patients with multiple myeloma

enthalten in: Cancer Medicine | 2023

von Nahi, H. | Afram, G. | Uttervall, K. | +8

5

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care

enthalten in: European journal of haematology | 2022

von Afram, G. | Chaireti, R. | Uttervall, K. | +6

CommentIn: Eur J Haematol. 2023 Feb;110(2):221. - PMID 36300853

6

Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma : Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment

enthalten in: Transplantation and cellular therapy | 2022

von Reinoso-Segura, M. | Caballero-Velázquez, T. | Herrera, P. | +12

7

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

enthalten in: Cell reports. Medicine | 2022

von Nahi, H. | Chrobok, M. | Meinke, S. | +20

CommentIn: Cell Rep Med. 2022 Feb 15;3(2):100537. - PMID 35243428

8

Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression‐free and overall survival in elderly myeloma patients compared to standard of care

enthalten in: European Journal of Haematology | 2022

von Afram, G. | Chaireti, R. | Uttervall, K. | +6

9

Primary plasma cell leukemia : consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage

enthalten in: Blood cancer journal | 2021

von Fernández de Larrea, C. | Kyle, R. | Rosiñol, L. | +26

10

Expert review on soft-tissue plasmacytomas in multiple myeloma : definition, disease assessment and treatment considerations

enthalten in: British journal of haematology | 2021

von Rosiñol, L. | Beksac, M. | Zamagni, E. | +35

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]